Benzyl (1-(tert-butyl)-3-(3-oxocyclopentyl)-1H-pyrazol-5-yl)carbamate

Catalog No. :
ACCJTN561
CAS No. :
2460255-78-9
Molecular Formula :
C20H25N3O3
Molecular Weight :
355.44

IUPAC Name:benzyl (1-(tert-butyl)-3-(3-oxocyclopentyl)-1H-pyrazol-5-yl)carbamate

Benzyl (1-(tert-butyl)-3-(3-oxocyclopentyl)-1H-pyrazol-5-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$57.00Login to see priceIn stockInquiry
1g98%$127.00Login to see priceIn stockInquiry
5g98%$379.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzyl (1-(tert-butyl)-3-(3-oxocyclopentyl)-1H-pyrazol-5-yl)carbamate
IUPAC Namebenzyl (1-(tert-butyl)-3-(3-oxocyclopentyl)-1H-pyrazol-5-yl)carbamate
MDL No.MFCD34468117
Molecular FormulaC20H25N3O3
Molecular Weight355.44
SMILESO=C(OCC1=CC=CC=C1)NC2=CC(C3CC(CC3)=O)=NN2C(C)(C)C
InChI KeyPCMHACWNZMLJQH-UHFFFAOYSA-N
SynonymCarbamic acid, N-[1-(1,1-dimethylethyl)-3-(3-oxocyclopentyl)-1H-pyrazol-5-yl]-, phenylmethyl ester;Benzyl (1-(tert-butyl)-3-(3-oxocyclopentyl)-1H-pyrazol-5-yl)carbamate;benzyl N-[2-tert-butyl-5-(3-oxocyclopentyl)pyrazol-3-yl]carbamate
CAS No.2460255-78-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACCJTN561 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCJTN561 route product structure diagram
    ACCJTN5612460255-78-9 In Stock
Inquiry

2. ACCJTN561 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCJTN561 route product structure diagram
    ACCJTN5612460255-78-9 In Stock
Inquiry

Comments (0)